Target
Aurora kinase B
Ligand
BDBM408751
Substrate
n/a
Meas. Tech.
Inhibition Assay
IC50
<100±n/a nM
Citation
 Sampson, PBLiu, YLi, SForrest, BTPauls, HWEdwards, LGFeher, MPatel, NKLaufer, R Kinase inhibitors and method of treating cancer US Patent  US10358436 Publication Date 7/23/2019 
Target
Name:
Aurora kinase B
Synonyms:
AIK2 | AIM-1 | AIM1 | AIRK2 | ARK2 | AURKB | AURKB_HUMAN | Aurora B kinase (aurB) | Aurora B-INCENP | Aurora kinase 2 | Aurora kinase B (AURKB) | Aurora-related kinase 2 | STK-1 | STK1 | STK12 | STK5 | Serine/threonine-protein kinase aurora B
Type:
Protein
Mol. Mass.:
39327.72
Organism:
Homo sapiens (Human)
Description:
Q96GD4
Residue:
344
Sequence:
MAQKENSYPWPYGRQTAPSGLSTLPQRVLRKEPVTPSALVLMSRSNVQPTAAPGQKVMENSSGTPDILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPMGAQDLISKLLRHNPSERLPLAQVSAHPWVRANSRRVLPPSALQSVA
  
Inhibitor
Name:
BDBM408751
Synonyms:
US10358436, Example A165
Type:
Small organic molecule
Emp. Form.:
C33H33N5O2
Mol. Mass.:
531.6474
SMILES:
NC(=O)CN1C(=O)[C@@]2(C[C@H]2c2ccc3c(\C=C\c4ccc(CN5CCCCC5)cc4)n[nH]c3c2)c2ccccc12 |r|
Structure:
Search PDB for entries with ligand similarity: